BLASTP 2.12.0+


Reference: Stephen F. Altschul, Thomas L. Madden, Alejandro A.
Schaffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and David J.
Lipman (1997), "Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs", Nucleic Acids Res. 25:3389-3402.


Reference for composition-based statistics: Alejandro A. Schaffer,
L. Aravind, Thomas L. Madden, Sergei Shavirin, John L. Spouge, Yuri
I. Wolf, Eugene V. Koonin, and Stephen F. Altschul (2001),
"Improving the accuracy of PSI-BLAST protein database searches with
composition-based statistics and other refinements", Nucleic Acids
Res. 29:2994-3005.



Database: VFDB_setB_pro.fas
           27,982 sequences; 13,298,383 total letters



Query= g753.t1

Length=331
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  61.2    1e-10
VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  61.6    2e-10
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  60.5    3e-10
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  59.3    8e-10
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  59.3    8e-10
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  59.3    9e-10
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  58.9    1e-09
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  58.9    1e-09
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  58.9    1e-09
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  58.5    1e-09
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  57.4    4e-09
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  57.0    5e-09
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  55.8    1e-08
VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC [M...  48.9    2e-06
VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC [M...  48.5    3e-06
VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  48.1    3e-06
VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC [M...  47.8    4e-06
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  47.8    4e-06
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  47.8    4e-06
VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC [M...  47.8    5e-06
VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC [M...  47.8    5e-06
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  47.8    5e-06
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  47.8    5e-06
VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC [M...  47.8    6e-06
VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC [M...  47.0    8e-06
VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC [M...  47.0    8e-06
VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC [M...  47.0    8e-06
VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC [M...  47.0    9e-06
VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC [M...  47.0    9e-06
VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC [M...  47.0    1e-05
VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC [M...  47.0    1e-05


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 61.2 bits (147),  Expect = 1e-10, Method: Compositional matrix adjust.
 Identities = 66/276 (24%), Positives = 122/276 (44%), Gaps = 22/276 (8%)

Query  4    PVVIGLAIAAIVAVIAGGTWWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGD  63
            PV+I L +   + +     + Y     +   +  NV     N    V G + ++ V    
Sbjct  10   PVIILLCVFLFILIYH---YSYLFPFTNNAFVVANVRPVAAN----VKGYITNIYVKNEQ  62

Query  64   TIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDLMLAGYRDEEIAQAAAAVRQ--AQA  121
             +K GQ L  +  APYE A  +A + V  A+AQ  L+L   + E+      A ++   + 
Sbjct  63   EVKKGQPLFTVFKAPYELAYRKAVSHVQEAKAQ--LLLFNKQVEKTKYLLQAQKELYEKF  120

Query  122  AYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIA  181
             +DY  N+        +   +S   +      ++ A + LK+ + +L      N++Q I 
Sbjct  121  RFDYEHNY-----SASRDHAVSKLTVNTMLKEKNAALSKLKALEKELE----VNQQQVIV  171

Query  182  QAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVW  241
            Q K  ++   A +  A++DL +TT+ A  NG +    V  G+ +     V  ++ T  ++
Sbjct  172  QKK-KIDSLIAVMKNAKIDLDETTVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLF  230

Query  242  VRAYVDERNLSQTQPGRDILLYTDGRP-DKPYHGKI  276
            ++A  +E +L + QPG  + ++       K YHG I
Sbjct  231  IQANFNETDLRRVQPGDKVSIFPRMYFGSKIYHGVI  266


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 61.6 bits (148),  Expect = 2e-10, Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 147/317 (46%), Gaps = 22/317 (7%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD     + 
Sbjct  42   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD--DNDV  95

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTI  142
            L   +A   + QA   +     ++   +QA A V   +A    AQ+   R+  L +S  +
Sbjct  96   LAYERAKNELVQA---VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAV  152

Query  143  SANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQ  202
            SA +L +AR++  QAQA +K+A  + S  R         + +  ++ A  +L  A L+L+
Sbjct  153  SAEELAHARTAVSQAQAAVKAALAEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLR  212

Query  203  DTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGRDILL  262
             T + APA+G +  R+V+ G  + AG+ ++ +     VWV A   E  L   + G+   L
Sbjct  213  RTQVRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAEL  272

Query  263  YTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDAD---  311
             +D  G+    Y G++ GF + T       P    T +    +V R  +RI++   D   
Sbjct  273  VSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNREDVDR  330

Query  312  DALRQGMPVTVKFNDEA  328
              LR G+ +TVK +  A
Sbjct  331  HPLRIGLSMTVKVDTSA  347


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 60.5 bits (145),  Expect = 3e-10, Method: Compositional matrix adjust.
 Identities = 89/321 (28%), Positives = 154/321 (48%), Gaps = 30/321 (9%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD    +N 
Sbjct  48   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD---DND  100

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEE----IAQAAAAVRQAQAAYDYAQNFYNRQQGLWK  138
            ++      +  +A+ +L+ A  ++       +QAAA V   +A    AQ+   R+  L +
Sbjct  101  VL------AYERAKNELIQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAE  154

Query  139  SRTISANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQ  198
            S  +SA +L +AR++  QAQA +K+A  + S  R     Q   + + +++ A  +L  A 
Sbjct  155  SGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAW  214

Query  199  LDLQDTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGR  258
            L+LQ T + APA+G +  R+V+ G  + AG+ ++ +     VWV A   E  L   + G+
Sbjct  215  LNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  274

Query  259  DILLYTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDA  310
               L +D  G+    Y G++ GF + T       P    T +    +V R  +RI++   
Sbjct  275  PAELVSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNRE  332

Query  311  D---DALRQGMPVTVKFNDEA  328
            D     LR G+ +TVK +  A
Sbjct  333  DVDRHPLRIGLSMTVKVDTSA  353


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 59.3 bits (142),  Expect = 8e-10, Method: Compositional matrix adjust.
 Identities = 88/317 (28%), Positives = 149/317 (47%), Gaps = 22/317 (7%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD     + 
Sbjct  42   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDD--NDV  95

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTI  142
            L   +A   + QA   +     ++   +QA A V   +A    AQ+   R+  L +S  +
Sbjct  96   LAYERAKNELVQA---VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAV  152

Query  143  SANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQ  202
            SA +L +AR++  QAQA +K+A  + S  R     Q   + + +++ A  +L  A L+LQ
Sbjct  153  SAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQ  212

Query  203  DTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGRDILL  262
             T + APA+G +  R+V+ G  + AG+ ++ +     VWV A   E  L   + G+   L
Sbjct  213  RTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAEL  272

Query  263  YTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDAD---  311
             +D  G+    Y G++ GF + T       P    T +    +V R  +RI++   D   
Sbjct  273  VSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNREDVDR  330

Query  312  DALRQGMPVTVKFNDEA  328
              LR G+ +TVK +  A
Sbjct  331  HPLRIGLSMTVKVDTSA  347


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 59.3 bits (142),  Expect = 8e-10, Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 153/321 (48%), Gaps = 30/321 (9%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD    +N 
Sbjct  48   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD---DND  100

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEE----IAQAAAAVRQAQAAYDYAQNFYNRQQGLWK  138
            ++      +  +A+ +L+ A  ++       +QA A V   +A    AQ+   R+  L +
Sbjct  101  VL------AYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAE  154

Query  139  SRTISANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQ  198
            S  +SA +L +AR++  QAQA +K+A  + S  R     Q   + + +++ A  +L  A 
Sbjct  155  SGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAW  214

Query  199  LDLQDTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGR  258
            L+LQ T + APA+G +  R+V+ G  + AG+ ++ +     VWV A   E  L   + G+
Sbjct  215  LNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  274

Query  259  DILLYTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDA  310
               L +D  G+    Y G++ GF + T       P    T +    +V R  +RI++   
Sbjct  275  PAELVSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNRE  332

Query  311  D---DALRQGMPVTVKFNDEA  328
            D     LR G+ +TVK +  A
Sbjct  333  DVDRHPLRIGLSMTVKVDTSA  353


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 59.3 bits (142),  Expect = 9e-10, Method: Compositional matrix adjust.
 Identities = 88/317 (28%), Positives = 149/317 (47%), Gaps = 22/317 (7%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD     + 
Sbjct  48   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD--DNDV  101

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTI  142
            L   +A   + QA   +     ++   +QAAA V   +A    AQ+   R+  L +S  +
Sbjct  102  LAYERAKNELVQA---VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAV  158

Query  143  SANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQ  202
            SA +L +AR++  QAQA +K+A  + S  R     Q   + +  ++ A  +L  A L+LQ
Sbjct  159  SAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPEVQTAIGRLKDAWLNLQ  218

Query  203  DTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGRDILL  262
             T + APA+G +  R+V+ G  + AG+ ++ +     +WV A   E  L   + G+   L
Sbjct  219  RTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPAEL  278

Query  263  YTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDAD---  311
             +D  G+    Y G++ GF + T       P    T +    +V R  +RI++   D   
Sbjct  279  VSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNREDVDR  336

Query  312  DALRQGMPVTVKFNDEA  328
              LR G+ +TVK +  A
Sbjct  337  HPLRIGLSMTVKVDTSA  353


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 58.9 bits (141),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 92/324 (28%), Positives = 151/324 (47%), Gaps = 36/324 (11%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDH----AP  78
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD       
Sbjct  42   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLA  97

Query  79   YE---NALMQAKAGVSVAQAQYDLMLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQG  135
            YE   N L+QA     V Q +        ++   +QA A V   +A    AQ+   R+  
Sbjct  98   YERAKNELIQA-----VRQNRR-------QNAATSQAGAQVALRRADLARAQDDLRRRSA  145

Query  136  LWKSRTISANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLA  195
            L +S  +SA +L +AR++  QAQA +K+A  + S  R     Q   + + +++ A  +L 
Sbjct  146  LAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLK  205

Query  196  QAQLDLQDTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQ  255
             A L+LQ T + APA+G +  R+V+ G  + AG+ ++ +     VWV A   E  L   +
Sbjct  206  DAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMK  265

Query  256  PGRDILLYTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIV  307
             G+   L +D  G+    Y G++ GF + T       P    T +    +V R  +RI++
Sbjct  266  IGQPAELVSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVL  323

Query  308  TDAD---DALRQGMPVTVKFNDEA  328
               D     LR G+ +TVK +  A
Sbjct  324  NREDVDRHPLRIGLSMTVKVDTSA  347


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 58.9 bits (141),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 88/317 (28%), Positives = 149/317 (47%), Gaps = 22/317 (7%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD     + 
Sbjct  42   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD--DNDV  95

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTI  142
            L   +A   + QA   +     ++   +QA A V   +A    AQ+   R+  L +S  +
Sbjct  96   LAYERAKNELVQA---VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAV  152

Query  143  SANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQ  202
            SA +L +AR++  QAQA +K+A  + S  R     Q   + + +++ A  +L  A L+LQ
Sbjct  153  SAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQ  212

Query  203  DTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGRDILL  262
             T + APA+G +  R+V+ G  + AG+ ++ +     VWV A   E  L   + G+   L
Sbjct  213  RTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAEL  272

Query  263  YTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDAD---  311
             +D  G+    Y G++ GF + T       P    T +    +V R  +RI++   D   
Sbjct  273  VSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNREDVDR  330

Query  312  DALRQGMPVTVKFNDEA  328
              LR G+ +TVK +  A
Sbjct  331  HPLRIGLSMTVKVDTSA  347


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 58.9 bits (141),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 153/321 (48%), Gaps = 30/321 (9%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD    +N 
Sbjct  42   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD---DND  94

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEE----IAQAAAAVRQAQAAYDYAQNFYNRQQGLWK  138
            ++      +  +A+ +L+ A  ++       +QA A V   +A    AQ+   R+  L +
Sbjct  95   VL------AYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAE  148

Query  139  SRTISANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQ  198
            S  +SA +L +AR++  QAQA +K+A  + S  R     Q   + + +++ A  +L  A 
Sbjct  149  SGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAW  208

Query  199  LDLQDTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGR  258
            L+LQ T + APA+G +  R+V+ G  + AG+ ++ +     VWV A   E  L   + G+
Sbjct  209  LNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  268

Query  259  DILLYTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDA  310
               L +D  G+    Y G++ GF + T       P    T +    +V R  +RI++   
Sbjct  269  PAELVSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNRE  326

Query  311  D---DALRQGMPVTVKFNDEA  328
            D     LR G+ +TVK +  A
Sbjct  327  DVDRHPLRIGLSMTVKVDTSA  347


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 58.5 bits (140),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 88/317 (28%), Positives = 149/317 (47%), Gaps = 22/317 (7%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD     + 
Sbjct  42   WWQHEEETEDAYVAG----RVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDD--NDV  95

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTI  142
            L   +A   + QA   +     ++   +QA A V   +A    AQ+   R+  L +S  +
Sbjct  96   LAYERAKNELVQA---VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAV  152

Query  143  SANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQ  202
            SA +L +AR++  QAQA +K+A  + S  R     Q   + + +++ A  +L  A L+LQ
Sbjct  153  SAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQ  212

Query  203  DTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGRDILL  262
             T + APA+G +  R+V+ G  + AG+ ++ +     VWV A   E  L   + G+   L
Sbjct  213  RTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAEL  272

Query  263  YTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDAD---  311
             +D  G+    Y G++ GF + T       P    T +    +V R  +RI++   D   
Sbjct  273  VSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNREDVDR  330

Query  312  DALRQGMPVTVKFNDEA  328
              LR G+ +TVK +  A
Sbjct  331  HPLRIGLSMTVKVDTSA  347


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 57.4 bits (137),  Expect = 4e-09, Method: Compositional matrix adjust.
 Identities = 87/321 (27%), Positives = 152/321 (47%), Gaps = 30/321 (9%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD    +N 
Sbjct  42   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD---DND  94

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEE----IAQAAAAVRQAQAAYDYAQNFYNRQQGLWK  138
            ++      +  +A+ +L+ A  ++       +QA A V   +A    AQ+   R+  L +
Sbjct  95   VL------AYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAE  148

Query  139  SRTISANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQ  198
            S  +SA +L +AR++  QAQA +K+A  + S  R     Q   + + +++ A  +L  A 
Sbjct  149  SGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAW  208

Query  199  LDLQDTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGR  258
            L+LQ T +  PA+G +  R+V+ G  + AG+ ++ +     VWV A   E  L   + G+
Sbjct  209  LNLQRTQIRTPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  268

Query  259  DILLYTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDA  310
               L +D  G+    Y G++ GF + T       P    T +    +V R  +RI++   
Sbjct  269  PAELVSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNRE  326

Query  311  D---DALRQGMPVTVKFNDEA  328
            D     LR G+ +TVK +  A
Sbjct  327  DVDRHPLRIGLSMTVKVDTSA  347


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 57.0 bits (136),  Expect = 5e-09, Method: Compositional matrix adjust.
 Identities = 87/321 (27%), Positives = 152/321 (47%), Gaps = 30/321 (9%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD    +N 
Sbjct  48   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD---DND  100

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEE----IAQAAAAVRQAQAAYDYAQNFYNRQQGLWK  138
            ++      +  +A+ +L+ A  ++ +     +QA A V   +A    AQ+   R+  L +
Sbjct  101  VL------AYERAKNELIQAVRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALAE  154

Query  139  SRTISANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQ  198
            S  +SA +L +AR++  QAQA +K+A  + S  R     Q   + + +++ A  +L  A 
Sbjct  155  SGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVALREQPAVQTAIGRLKDAW  214

Query  199  LDLQDTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGR  258
            L+LQ T + AP +G +  R+V+ G  + AG+ ++ +     VWV A   E  L   + G+
Sbjct  215  LNLQRTQIRAPTDGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  274

Query  259  DILLYTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDA  310
               L +D  G+    Y G + GF + T       P    T +    +V R  +RI++   
Sbjct  275  PAELVSDLYGK-QIVYRGMVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNRE  332

Query  311  D---DALRQGMPVTVKFNDEA  328
            D     LR G+ +TVK +  A
Sbjct  333  DVDRHPLRIGLSMTVKVDTSA  353


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 55.8 bits (133),  Expect = 1e-08, Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 148/317 (47%), Gaps = 22/317 (7%)

Query  23   WWYQSRQDDGLTLYGNVDIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENA  82
            WW    + +   + G    R V ++ + GG +  +  D+ D +K G VL  LD     + 
Sbjct  48   WWQHEEETEDAYVAG----RVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD--DNDV  101

Query  83   LMQAKAGVSVAQAQYDLMLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTI  142
            L   +A   + QA   +     ++   +QA A V   +A    AQ+   R+  L +S  +
Sbjct  102  LAYERAKNELVQA---VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAV  158

Query  143  SANDLENARSSRDQAQATLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQ  202
            SA +L +AR++  QAQA +K+A  + S  R     Q   + + +++ A  +L  A L+LQ
Sbjct  159  SAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQ  218

Query  203  DTTLIAPANGTLLTRAVEPGSMLNAGSTVLTLSLTRPVWVRAYVDERNLSQTQPGRDILL  262
             T + A A+G +  R+V+ G  + AG+ ++ +     VWV A   E  L   + G+   L
Sbjct  219  RTQIRASADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAEL  278

Query  263  YTD--GRPDKPYHGKI-GFVSPTA---EFTPKTVETPDLRTDLVYR--LRIIVTDAD---  311
             +D  G+    Y G++ GF + T       P    T +    +V R  +RI++   D   
Sbjct  279  VSDLYGK-QIVYRGRVAGFSAGTGSAFSLIPAQNATGNW-IKVVQRVPVRIVLNREDVDR  336

Query  312  DALRQGMPVTVKFNDEA  328
              LR G+ +TVK +  A
Sbjct  337  HPLRIGLSMTVKVDTSA  353


>VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=412

 Score = 48.9 bits (115),  Expect = 2e-06, Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 105/259 (41%), Gaps = 66/259 (25%)

Query  40   DIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDL  99
             +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA    
Sbjct  69   SLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATL--  126

Query  100  MLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQA  159
                               A+A  D A     R + L  +  IS  + + A +++  A+A
Sbjct  127  -------------------AKADADLA-----RYKPLVSADAISKQEYDAAVTAKRSAEA  162

Query  160  TLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAV  219
             +K+AQ                          A +  A ++L  + + AP +G +    V
Sbjct  163  GVKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKV  196

Query  220  EPGSMLNAGSTVL--TLSLTRPVWVRAYVDERNLSQT--QPGRDILLYTDG------RPD  269
              G++LNAG T +  T+  T P++V        + +   Q     LL  DG      + D
Sbjct  197  SEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGAIAVGIKFD  256

Query  270  K----PYHGKIGFVSPTAE  284
                 P  G++ F  PT E
Sbjct  257  DGTVYPEKGRLLFADPTVE  275


>VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae NCCP11945]
Length=412

 Score = 48.5 bits (114),  Expect = 3e-06, Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 54/204 (26%)

Query  41   IRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDLM  100
            +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA     
Sbjct  70   LRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATL---  126

Query  101  LAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQAT  160
                              A+A  D A     R + L  +  IS  + + A +++  A+A 
Sbjct  127  ------------------AKADADLA-----RYKPLVSADAISKQEYDAAVTAKRSAEAG  163

Query  161  LKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAVE  220
            +K+AQ                          A +  A ++L  + + AP +G +    V 
Sbjct  164  VKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  221  PGSMLNAGSTVL--TLSLTRPVWV  242
             G++LNAG T +  T+  T P++V
Sbjct  198  EGTLLNAGDTTVLATIRQTNPMYV  221


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 48.1 bits (113),  Expect = 3e-06, Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 57/213 (27%)

Query  41   IRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDLM  100
            I  V+I  +V G+L +++  +G  +K G +L  +D  P+E  L +AKA ++ A+AQ    
Sbjct  69   IDQVDIRPQVSGKLVAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVT--  126

Query  101  LAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQAT  160
                                    Y  +  +R Q L +S  +S  +L+ A          
Sbjct  127  ------------------------YTASNLSRIQRLIQSNAVSRQELDLA----------  152

Query  161  LKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAVE  220
                            E D   A A+L+ A+A +  A+L+L+ T + AP +G +    V 
Sbjct  153  ----------------ENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVT  196

Query  221  PGSMLNA--GSTVLT--LSLTRPVWVRAYVDER  249
             G++++A  G+ VLT  +S++R ++    VDE+
Sbjct  197  VGNVVSAGNGAQVLTSLVSVSR-LYASFDVDEQ  228


>VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis FAM18]
Length=412

 Score = 47.8 bits (112),  Expect = 4e-06, Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 88/205 (43%), Gaps = 54/205 (26%)

Query  40   DIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDL  99
             +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA    
Sbjct  69   SLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATL--  126

Query  100  MLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQA  159
                               A+A  D A     R + L  +  +S  + + A +++  A+A
Sbjct  127  -------------------AKADADLA-----RYKPLVAAEAVSRQEYDAAVTAKRSAEA  162

Query  160  TLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAV  219
             +K+AQ                          A +  A ++L  + + AP +G +    V
Sbjct  163  GVKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKV  196

Query  220  EPGSMLNAGSTVL--TLSLTRPVWV  242
              G++LNAG T +  T+  T P++V
Sbjct  197  SEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 47.8 bits (112),  Expect = 4e-06, Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 57/213 (27%)

Query  41   IRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDLM  100
            I  V+I  +V G+L +++  +G  +K G +L  +D  P+E  L +AKA ++ A+AQ    
Sbjct  69   IDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVT--  126

Query  101  LAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQAT  160
                                    Y  +  +R Q L +S  +S  +L+ A          
Sbjct  127  ------------------------YTASNLSRIQRLIQSNAVSRQELDLA----------  152

Query  161  LKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAVE  220
                            E D   A A+L+ A+A +  A+L+L+ T + AP +G +    V 
Sbjct  153  ----------------ENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVT  196

Query  221  PGSMLNA--GSTVLT--LSLTRPVWVRAYVDER  249
             G++++A  G+ VLT  +S++R ++    VDE+
Sbjct  197  VGNVVSAGNGAQVLTSLVSVSR-LYASFDVDEQ  228


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 47.8 bits (112),  Expect = 4e-06, Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 57/213 (27%)

Query  41   IRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDLM  100
            I  V+I  +V G+L +++  +G  +K G +L  +D  P+E  L +AKA ++ A+AQ    
Sbjct  69   IDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVT--  126

Query  101  LAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQAT  160
                                    Y  +  +R Q L +S  +S  +L+ A          
Sbjct  127  ------------------------YTASNLSRIQRLIQSNAVSRQELDLA----------  152

Query  161  LKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAVE  220
                            E D   A A+L+ A+A +  A+L+L+ T + AP +G +    V 
Sbjct  153  ----------------ENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVT  196

Query  221  PGSMLNA--GSTVLT--LSLTRPVWVRAYVDER  249
             G++++A  G+ VLT  +S++R ++    VDE+
Sbjct  197  VGNVVSAGNGAQVLTSLVSVSR-LYASFDVDEQ  228


>VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis Z2491]
Length=412

 Score = 47.8 bits (112),  Expect = 5e-06, Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 88/205 (43%), Gaps = 54/205 (26%)

Query  40   DIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDL  99
             +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA    
Sbjct  69   SLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATL--  126

Query  100  MLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQA  159
                               A+A  D A     R + L  +  +S  + + A +++  A+A
Sbjct  127  -------------------AKADADLA-----RYKPLVAAEAVSRQEYDAAVTAKRSAEA  162

Query  160  TLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAV  219
             +K+AQ                          A +  A ++L  + + AP +G +    V
Sbjct  163  GVKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKV  196

Query  220  EPGSMLNAGSTVL--TLSLTRPVWV  242
              G++LNAG T +  T+  T P++V
Sbjct  197  SEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria lactamica 020-06]
Length=412

 Score = 47.8 bits (112),  Expect = 5e-06, Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 88/205 (43%), Gaps = 54/205 (26%)

Query  40   DIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDL  99
             +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA    
Sbjct  69   SLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATL--  126

Query  100  MLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQA  159
                               A+A  D A     R + L  +  +S  + + A +++  A+A
Sbjct  127  -------------------AKADADLA-----RYKPLVAAEAVSRQEYDAAVTAKRSAEA  162

Query  160  TLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAV  219
             +K+AQ                          A +  A ++L  + + AP +G +    V
Sbjct  163  GVKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKV  196

Query  220  EPGSMLNAGSTVL--TLSLTRPVWV  242
              G++LNAG T +  T+  T P++V
Sbjct  197  SEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 47.8 bits (112),  Expect = 5e-06, Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 57/213 (27%)

Query  41   IRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDLM  100
            I  V+I  +V G+L +++  +G  +K G +L  +D  P+E  L +AKA ++ A+AQ    
Sbjct  69   IDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVT--  126

Query  101  LAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQAT  160
                                    Y  +  +R Q L +S  +S  +L+ A          
Sbjct  127  ------------------------YTASNLSRIQRLIQSNAVSRQELDLA----------  152

Query  161  LKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAVE  220
                            E D   A A+L+ A+A +  A+L+L+ T + AP +G +    V 
Sbjct  153  ----------------ENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVT  196

Query  221  PGSMLNA--GSTVLT--LSLTRPVWVRAYVDER  249
             G++++A  G+ VLT  +S++R ++    VDE+
Sbjct  197  VGNVVSAGNGAQVLTSLVSVSR-LYASFDVDEQ  228


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 47.8 bits (112),  Expect = 5e-06, Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 57/213 (27%)

Query  41   IRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDLM  100
            I  V+I  +V G+L +++  +G  +K G +L  +D  P+E  L +AKA ++ A+AQ    
Sbjct  45   IDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVT--  102

Query  101  LAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQAT  160
                                    Y  +  +R Q L +S  +S  +L+ A          
Sbjct  103  ------------------------YTASNLSRIQRLIQSNAVSRQELDLA----------  128

Query  161  LKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAVE  220
                            E D   A A+L+ A+A +  A+L+L+ T + AP +G +    V 
Sbjct  129  ----------------ENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVT  172

Query  221  PGSMLNA--GSTVLT--LSLTRPVWVRAYVDER  249
             G++++A  G+ VLT  +S++R ++    VDE+
Sbjct  173  VGNVVSAGNGAQVLTSLVSVSR-LYASFDVDEQ  204


>VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240355]
Length=412

 Score = 47.8 bits (112),  Expect = 6e-06, Method: Compositional matrix adjust.
 Identities = 53/205 (26%), Positives = 90/205 (44%), Gaps = 54/205 (26%)

Query  40   DIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDL  99
             +RT ++  +VGG +      EG  ++AGQ L ++D + YE +L  A+A ++ AQA    
Sbjct  69   SLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEASLESARAQLATAQATL--  126

Query  100  MLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQA  159
                               A+A  D A     R + L  +  IS  + + A +++  A+A
Sbjct  127  -------------------AKADADLA-----RYKPLVAADAISKQEYDAAVTAKRSAEA  162

Query  160  TLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAV  219
             +K+AQ                          A +  A + L  + + AP +G +    V
Sbjct  163  GVKAAQ--------------------------AAIKSAGISLNRSRITAPISGFIGQSKV  196

Query  220  EPGSMLNAG-STVL-TLSLTRPVWV  242
              G++LNAG +TVL T+  T P++V
Sbjct  197  SEGTLLNAGDATVLATIRQTNPMYV  221


>VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha14]
Length=412

 Score = 47.0 bits (110),  Expect = 8e-06, Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 88/205 (43%), Gaps = 54/205 (26%)

Query  40   DIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDL  99
             +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA    
Sbjct  69   SLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATL--  126

Query  100  MLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQA  159
                               A+A  D A     R + L  +  +S  + + A +++  A+A
Sbjct  127  -------------------AKADADLA-----RYKPLVAAEAVSRQEYDAAVTAKRSAEA  162

Query  160  TLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAV  219
             +K+AQ                          A +  A ++L  + + AP +G +    V
Sbjct  163  GVKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKV  196

Query  220  EPGSMLNAGSTVL--TLSLTRPVWV  242
              G++LNAG T +  T+  T P++V
Sbjct  197  SEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis G2136]
Length=412

 Score = 47.0 bits (110),  Expect = 8e-06, Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 88/205 (43%), Gaps = 54/205 (26%)

Query  40   DIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDL  99
             +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA    
Sbjct  69   SLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATL--  126

Query  100  MLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQA  159
                               A+A  D A     R + L  +  +S  + + A +++  A+A
Sbjct  127  -------------------AKADADLA-----RYKPLVAAEAVSRQEYDAAVTAKRSAEA  162

Query  160  TLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAV  219
             +K+AQ                          A +  A ++L  + + AP +G +    V
Sbjct  163  GVKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKV  196

Query  220  EPGSMLNAGSTVL--TLSLTRPVWV  242
              G++LNAG T +  T+  T P++V
Sbjct  197  SEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis WUE 2594]
Length=412

 Score = 47.0 bits (110),  Expect = 8e-06, Method: Compositional matrix adjust.
 Identities = 50/204 (25%), Positives = 88/204 (43%), Gaps = 54/204 (26%)

Query  41   IRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDLM  100
            +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA     
Sbjct  70   LRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATL---  126

Query  101  LAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQAT  160
                              A+A  D A     R + L  +  +S  + + A +++  A+A 
Sbjct  127  ------------------AKADADLA-----RYKPLVAAEAVSRQEYDAAVTAKRSAEAG  163

Query  161  LKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAVE  220
            +K+AQ                          A +  A ++L  + + AP +G +    V 
Sbjct  164  VKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  221  PGSMLNAGSTVL--TLSLTRPVWV  242
             G++LNAG T +  T+  T P++V
Sbjct  198  EGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis 8013]
Length=412

 Score = 47.0 bits (110),  Expect = 9e-06, Method: Compositional matrix adjust.
 Identities = 50/204 (25%), Positives = 88/204 (43%), Gaps = 54/204 (26%)

Query  41   IRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDLM  100
            +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA     
Sbjct  70   LRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATL---  126

Query  101  LAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQAT  160
                              A+A  D A     R + L  +  +S  + + A +++  A+A 
Sbjct  127  ------------------AKADADLA-----RYKPLVAAEAVSRQEYDAAVTAKRSAEAG  163

Query  161  LKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAVE  220
            +K+AQ                          A +  A ++L  + + AP +G +    V 
Sbjct  164  VKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  221  PGSMLNAGSTVL--TLSLTRPVWV  242
             G++LNAG T +  T+  T P++V
Sbjct  198  EGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis MC58]
Length=412

 Score = 47.0 bits (110),  Expect = 9e-06, Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 54/205 (26%)

Query  40   DIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDL  99
             +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA    
Sbjct  69   SLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATL--  126

Query  100  MLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQA  159
                               A+A  D A     R + L  +  +S  + + A +++  A+A
Sbjct  127  -------------------AKADADLA-----RYKPLVAAEAVSRQEYDAAVTAKRSAEA  162

Query  160  TLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAV  219
             +K+AQ                          A +  A + L  + + AP +G +    V
Sbjct  163  GVKAAQ--------------------------AAIKSAGISLNRSRITAPISGFIGQSKV  196

Query  220  EPGSMLNAG-STVL-TLSLTRPVWV  242
              G++LNAG +TVL T+  T P++V
Sbjct  197  SEGTLLNAGDATVLATIRQTNPMYV  221


>VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240149]
Length=412

 Score = 47.0 bits (110),  Expect = 1e-05, Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 88/205 (43%), Gaps = 54/205 (26%)

Query  40   DIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDL  99
             +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA    
Sbjct  69   SLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATL--  126

Query  100  MLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQA  159
                               A+A  D A     R + L  +  +S  + + A +++  A+A
Sbjct  127  -------------------AKADADLA-----RYKPLVAAEAVSRQEYDAAVTAKRSAEA  162

Query  160  TLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAV  219
             +K+AQ                          A +  A ++L  + + AP +G +    V
Sbjct  163  GVKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKV  196

Query  220  EPGSMLNAGSTVL--TLSLTRPVWV  242
              G++LNAG T +  T+  T P++V
Sbjct  197  SEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha710]
Length=412

 Score = 47.0 bits (110),  Expect = 1e-05, Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 88/205 (43%), Gaps = 54/205 (26%)

Query  40   DIRTVNISFRVGGRLASLNVDEGDTIKAGQVLGELDHAPYENALMQAKAGVSVAQAQYDL  99
             +RT ++  +VGG +      EG  ++AGQ L ++D + YE  L  A+A ++ AQA    
Sbjct  69   SLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATL--  126

Query  100  MLAGYRDEEIAQAAAAVRQAQAAYDYAQNFYNRQQGLWKSRTISANDLENARSSRDQAQA  159
                               A+A  D A     R + L  +  +S  + + A +++  A+A
Sbjct  127  -------------------AKADADLA-----RYKPLVAAEAVSRQEYDAAVTAKRSAEA  162

Query  160  TLKSAQDKLSQYRTGNREQDIAQAKASLEQAKAQLAQAQLDLQDTTLIAPANGTLLTRAV  219
             +K+AQ                          A +  A ++L  + + AP +G +    V
Sbjct  163  GVKAAQ--------------------------AAIKSAGINLNRSRITAPISGFIGQSKV  196

Query  220  EPGSMLNAGSTVL--TLSLTRPVWV  242
              G++LNAG T +  T+  T P++V
Sbjct  197  SEGTLLNAGDTTVLATIRQTNPMYV  221



Lambda      K        H        a         alpha
   0.315    0.130    0.367    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2425542273


  Database: VFDB_setB_pro.fas
    Posted date:  Apr 10, 2024  11:56 PM
  Number of letters in database: 13,298,383
  Number of sequences in database:  27,982



Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Neighboring words threshold: 11
Window for multiple hits: 40
